nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—ABCB1—esophageal cancer	0.829	1	CbGaD
Alfentanil—Shivering—Capecitabine—esophageal cancer	0.00241	0.0503	CcSEcCtD
Alfentanil—Myoclonus—Capecitabine—esophageal cancer	0.00149	0.0312	CcSEcCtD
Alfentanil—Pain—Carboplatin—esophageal cancer	0.00127	0.0265	CcSEcCtD
Alfentanil—Hiccups—Cisplatin—esophageal cancer	0.00122	0.0254	CcSEcCtD
Alfentanil—Body temperature increased—Carboplatin—esophageal cancer	0.00117	0.0245	CcSEcCtD
Alfentanil—Injection site pain—Capecitabine—esophageal cancer	0.0011	0.023	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.000912	0.0191	CcSEcCtD
Alfentanil—Blood pressure increased—Capecitabine—esophageal cancer	0.000897	0.0188	CcSEcCtD
Alfentanil—Hiccups—Capecitabine—esophageal cancer	0.000897	0.0188	CcSEcCtD
Alfentanil—Apnoea—Methotrexate—esophageal cancer	0.000787	0.0165	CcSEcCtD
Alfentanil—Bradycardia—Cisplatin—esophageal cancer	0.000622	0.013	CcSEcCtD
Alfentanil—Cardiac arrest—Capecitabine—esophageal cancer	0.000619	0.0129	CcSEcCtD
Alfentanil—Connective tissue disorder—Cisplatin—esophageal cancer	0.0006	0.0126	CcSEcCtD
Alfentanil—Visual impairment—Cisplatin—esophageal cancer	0.000589	0.0123	CcSEcCtD
Alfentanil—Eye disorder—Cisplatin—esophageal cancer	0.000571	0.0119	CcSEcCtD
Alfentanil—Cardiac disorder—Cisplatin—esophageal cancer	0.000567	0.0119	CcSEcCtD
Alfentanil—Bronchospasm—Capecitabine—esophageal cancer	0.000553	0.0116	CcSEcCtD
Alfentanil—Immune system disorder—Cisplatin—esophageal cancer	0.000552	0.0115	CcSEcCtD
Alfentanil—Mediastinal disorder—Cisplatin—esophageal cancer	0.000551	0.0115	CcSEcCtD
Alfentanil—Arrhythmia—Cisplatin—esophageal cancer	0.000546	0.0114	CcSEcCtD
Alfentanil—Erythema—Cisplatin—esophageal cancer	0.000532	0.0111	CcSEcCtD
Alfentanil—Visual disturbance—Methotrexate—esophageal cancer	0.000511	0.0107	CcSEcCtD
Alfentanil—Vision blurred—Cisplatin—esophageal cancer	0.000501	0.0105	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000501	0.0105	CcSEcCtD
Alfentanil—Epistaxis—Capecitabine—esophageal cancer	0.000473	0.0099	CcSEcCtD
Alfentanil—Convulsion—Cisplatin—esophageal cancer	0.000461	0.00964	CcSEcCtD
Alfentanil—Bradycardia—Capecitabine—esophageal cancer	0.000458	0.00959	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00045	0.0094	CcSEcCtD
Alfentanil—Connective tissue disorder—Capecitabine—esophageal cancer	0.000442	0.00925	CcSEcCtD
Alfentanil—Anaphylactic shock—Cisplatin—esophageal cancer	0.000434	0.00908	CcSEcCtD
Alfentanil—Visual impairment—Capecitabine—esophageal cancer	0.000434	0.00908	CcSEcCtD
Alfentanil—Nervous system disorder—Cisplatin—esophageal cancer	0.000426	0.0089	CcSEcCtD
Alfentanil—Tachycardia—Cisplatin—esophageal cancer	0.000424	0.00886	CcSEcCtD
Alfentanil—Skin disorder—Cisplatin—esophageal cancer	0.000422	0.00882	CcSEcCtD
Alfentanil—Eye disorder—Capecitabine—esophageal cancer	0.000421	0.0088	CcSEcCtD
Alfentanil—Hyperhidrosis—Cisplatin—esophageal cancer	0.00042	0.00877	CcSEcCtD
Alfentanil—Cardiac disorder—Capecitabine—esophageal cancer	0.000418	0.00874	CcSEcCtD
Alfentanil—Angiopathy—Capecitabine—esophageal cancer	0.000409	0.00854	CcSEcCtD
Alfentanil—Immune system disorder—Capecitabine—esophageal cancer	0.000407	0.00851	CcSEcCtD
Alfentanil—Mediastinal disorder—Capecitabine—esophageal cancer	0.000406	0.00849	CcSEcCtD
Alfentanil—Hypotension—Cisplatin—esophageal cancer	0.000406	0.00848	CcSEcCtD
Alfentanil—Chills—Capecitabine—esophageal cancer	0.000404	0.00845	CcSEcCtD
Alfentanil—Arrhythmia—Capecitabine—esophageal cancer	0.000402	0.00841	CcSEcCtD
Alfentanil—Mental disorder—Capecitabine—esophageal cancer	0.000394	0.00825	CcSEcCtD
Alfentanil—Erythema—Capecitabine—esophageal cancer	0.000392	0.0082	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000375	0.00784	CcSEcCtD
Alfentanil—Drowsiness—Methotrexate—esophageal cancer	0.000373	0.00781	CcSEcCtD
Alfentanil—Pain—Cisplatin—esophageal cancer	0.000371	0.00776	CcSEcCtD
Alfentanil—Vision blurred—Capecitabine—esophageal cancer	0.000369	0.00773	CcSEcCtD
Alfentanil—Feeling abnormal—Cisplatin—esophageal cancer	0.000358	0.00748	CcSEcCtD
Alfentanil—Epistaxis—Methotrexate—esophageal cancer	0.000352	0.00737	CcSEcCtD
Alfentanil—Loss of consciousness—Capecitabine—esophageal cancer	0.000345	0.00721	CcSEcCtD
Alfentanil—Body temperature increased—Cisplatin—esophageal cancer	0.000343	0.00718	CcSEcCtD
Alfentanil—Cough—Capecitabine—esophageal cancer	0.000342	0.00715	CcSEcCtD
Alfentanil—Hypertension—Capecitabine—esophageal cancer	0.000338	0.00708	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000331	0.00693	CcSEcCtD
Alfentanil—Visual impairment—Methotrexate—esophageal cancer	0.000323	0.00676	CcSEcCtD
Alfentanil—Confusional state—Capecitabine—esophageal cancer	0.000323	0.00675	CcSEcCtD
Alfentanil—Hypersensitivity—Cisplatin—esophageal cancer	0.00032	0.00669	CcSEcCtD
Alfentanil—Nervous system disorder—Capecitabine—esophageal cancer	0.000314	0.00656	CcSEcCtD
Alfentanil—Eye disorder—Methotrexate—esophageal cancer	0.000313	0.00655	CcSEcCtD
Alfentanil—Tachycardia—Capecitabine—esophageal cancer	0.000312	0.00653	CcSEcCtD
Alfentanil—Asthenia—Cisplatin—esophageal cancer	0.000311	0.00651	CcSEcCtD
Alfentanil—Cardiac disorder—Methotrexate—esophageal cancer	0.000311	0.00651	CcSEcCtD
Alfentanil—Skin disorder—Capecitabine—esophageal cancer	0.000311	0.0065	CcSEcCtD
Alfentanil—Hyperhidrosis—Capecitabine—esophageal cancer	0.000309	0.00647	CcSEcCtD
Alfentanil—Angiopathy—Methotrexate—esophageal cancer	0.000304	0.00636	CcSEcCtD
Alfentanil—Immune system disorder—Methotrexate—esophageal cancer	0.000303	0.00633	CcSEcCtD
Alfentanil—Mediastinal disorder—Methotrexate—esophageal cancer	0.000302	0.00632	CcSEcCtD
Alfentanil—Chills—Methotrexate—esophageal cancer	0.000301	0.00629	CcSEcCtD
Alfentanil—Hypotension—Capecitabine—esophageal cancer	0.000299	0.00625	CcSEcCtD
Alfentanil—Mental disorder—Methotrexate—esophageal cancer	0.000294	0.00614	CcSEcCtD
Alfentanil—Erythema—Methotrexate—esophageal cancer	0.000292	0.0061	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000276	0.00578	CcSEcCtD
Alfentanil—Vomiting—Cisplatin—esophageal cancer	0.000276	0.00577	CcSEcCtD
Alfentanil—Fatigue—Capecitabine—esophageal cancer	0.000276	0.00577	CcSEcCtD
Alfentanil—Vision blurred—Methotrexate—esophageal cancer	0.000275	0.00575	CcSEcCtD
Alfentanil—Rash—Cisplatin—esophageal cancer	0.000274	0.00572	CcSEcCtD
Alfentanil—Pain—Capecitabine—esophageal cancer	0.000274	0.00572	CcSEcCtD
Alfentanil—Dermatitis—Cisplatin—esophageal cancer	0.000273	0.00572	CcSEcCtD
Alfentanil—Feeling abnormal—Capecitabine—esophageal cancer	0.000264	0.00551	CcSEcCtD
Alfentanil—Nausea—Cisplatin—esophageal cancer	0.000258	0.00539	CcSEcCtD
Alfentanil—Cough—Methotrexate—esophageal cancer	0.000255	0.00533	CcSEcCtD
Alfentanil—Urticaria—Capecitabine—esophageal cancer	0.000254	0.00532	CcSEcCtD
Alfentanil—Body temperature increased—Capecitabine—esophageal cancer	0.000253	0.00529	CcSEcCtD
Alfentanil—Convulsion—Methotrexate—esophageal cancer	0.000253	0.00529	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000247	0.00516	CcSEcCtD
Alfentanil—Confusional state—Methotrexate—esophageal cancer	0.00024	0.00502	CcSEcCtD
Alfentanil—Anaphylactic shock—Methotrexate—esophageal cancer	0.000238	0.00498	CcSEcCtD
Alfentanil—Hypersensitivity—Capecitabine—esophageal cancer	0.000236	0.00493	CcSEcCtD
Alfentanil—Nervous system disorder—Methotrexate—esophageal cancer	0.000234	0.00488	CcSEcCtD
Alfentanil—Skin disorder—Methotrexate—esophageal cancer	0.000231	0.00484	CcSEcCtD
Alfentanil—Hyperhidrosis—Methotrexate—esophageal cancer	0.00023	0.00482	CcSEcCtD
Alfentanil—Asthenia—Capecitabine—esophageal cancer	0.00023	0.0048	CcSEcCtD
Alfentanil—Pruritus—Capecitabine—esophageal cancer	0.000226	0.00473	CcSEcCtD
Alfentanil—Hypotension—Methotrexate—esophageal cancer	0.000223	0.00465	CcSEcCtD
Alfentanil—Somnolence—Methotrexate—esophageal cancer	0.000212	0.00443	CcSEcCtD
Alfentanil—Dizziness—Capecitabine—esophageal cancer	0.000212	0.00442	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000206	0.0043	CcSEcCtD
Alfentanil—Fatigue—Methotrexate—esophageal cancer	0.000205	0.00429	CcSEcCtD
Alfentanil—Pain—Methotrexate—esophageal cancer	0.000204	0.00426	CcSEcCtD
Alfentanil—Vomiting—Capecitabine—esophageal cancer	0.000203	0.00425	CcSEcCtD
Alfentanil—Rash—Capecitabine—esophageal cancer	0.000202	0.00422	CcSEcCtD
Alfentanil—Dermatitis—Capecitabine—esophageal cancer	0.000202	0.00421	CcSEcCtD
Alfentanil—Headache—Capecitabine—esophageal cancer	0.0002	0.00419	CcSEcCtD
Alfentanil—Feeling abnormal—Methotrexate—esophageal cancer	0.000196	0.0041	CcSEcCtD
Alfentanil—Nausea—Capecitabine—esophageal cancer	0.00019	0.00397	CcSEcCtD
Alfentanil—Urticaria—Methotrexate—esophageal cancer	0.000189	0.00396	CcSEcCtD
Alfentanil—Body temperature increased—Methotrexate—esophageal cancer	0.000188	0.00394	CcSEcCtD
Alfentanil—Hypersensitivity—Methotrexate—esophageal cancer	0.000175	0.00367	CcSEcCtD
Alfentanil—Asthenia—Methotrexate—esophageal cancer	0.000171	0.00357	CcSEcCtD
Alfentanil—Pruritus—Methotrexate—esophageal cancer	0.000168	0.00352	CcSEcCtD
Alfentanil—Dizziness—Methotrexate—esophageal cancer	0.000157	0.00329	CcSEcCtD
Alfentanil—Vomiting—Methotrexate—esophageal cancer	0.000151	0.00317	CcSEcCtD
Alfentanil—Rash—Methotrexate—esophageal cancer	0.00015	0.00314	CcSEcCtD
Alfentanil—Dermatitis—Methotrexate—esophageal cancer	0.00015	0.00314	CcSEcCtD
Alfentanil—Headache—Methotrexate—esophageal cancer	0.000149	0.00312	CcSEcCtD
Alfentanil—Nausea—Methotrexate—esophageal cancer	0.000141	0.00296	CcSEcCtD
Alfentanil—OPRM1—GPCR downstream signaling—CXCL2—esophageal cancer	0.00011	0.000888	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—WWOX—esophageal cancer	0.000109	0.000882	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—GNG7—esophageal cancer	0.000106	0.000854	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ADH7—esophageal cancer	0.000104	0.000844	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PLCE1—esophageal cancer	0.000104	0.000844	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—SLC52A3—esophageal cancer	0.000104	0.000844	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—BLVRB—esophageal cancer	0.000104	0.000844	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FKBP1A—esophageal cancer	0.000104	0.000839	CbGpPWpGaD
Alfentanil—ALB—Folate Metabolism—TP53—esophageal cancer	0.000103	0.00083	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—ANXA1—esophageal cancer	0.000102	0.000826	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—WIF1—esophageal cancer	0.000101	0.00082	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000101	0.000818	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000101	0.000815	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—CXCL2—esophageal cancer	9.97e-05	0.000807	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—SST—esophageal cancer	9.93e-05	0.000803	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—GHRL—esophageal cancer	9.67e-05	0.000783	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	9.59e-05	0.000776	CbGpPWpGaD
Alfentanil—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	9.46e-05	0.000766	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CSNK1A1—esophageal cancer	9.36e-05	0.000757	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—ANXA1—esophageal cancer	9.27e-05	0.00075	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ADH1B—esophageal cancer	9.14e-05	0.00074	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—GNG7—esophageal cancer	9.14e-05	0.000739	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	9.02e-05	0.00073	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—SST—esophageal cancer	9.02e-05	0.000729	CbGpPWpGaD
Alfentanil—ALB—Metabolism—SLC52A3—esophageal cancer	8.98e-05	0.000727	CbGpPWpGaD
Alfentanil—ALB—Metabolism—BLVRB—esophageal cancer	8.98e-05	0.000727	CbGpPWpGaD
Alfentanil—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	8.9e-05	0.00072	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—SLC10A2—esophageal cancer	8.87e-05	0.000717	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CA1—esophageal cancer	8.87e-05	0.000717	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	8.82e-05	0.000714	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—GHRL—esophageal cancer	8.79e-05	0.000711	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PFN1—esophageal cancer	8.75e-05	0.000708	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—TYMP—esophageal cancer	8.74e-05	0.000707	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—HSPA5—esophageal cancer	8.61e-05	0.000696	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CYP26A1—esophageal cancer	8.5e-05	0.000688	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ALOX15—esophageal cancer	8.28e-05	0.00067	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CA2—esophageal cancer	8.11e-05	0.000656	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	8.03e-05	0.000649	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	8.01e-05	0.000648	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	7.92e-05	0.000641	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—TPI1—esophageal cancer	7.9e-05	0.000639	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GSTO1—esophageal cancer	7.9e-05	0.000639	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	7.88e-05	0.000638	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—BLVRB—esophageal cancer	7.87e-05	0.000637	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SLC52A3—esophageal cancer	7.87e-05	0.000637	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ELMO1—esophageal cancer	7.86e-05	0.000636	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AKAP13—esophageal cancer	7.68e-05	0.000622	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CA1—esophageal cancer	7.63e-05	0.000618	CbGpPWpGaD
Alfentanil—ALB—Metabolism—SLC10A2—esophageal cancer	7.63e-05	0.000618	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ALDOB—esophageal cancer	7.58e-05	0.000613	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PLCE1—esophageal cancer	7.54e-05	0.00061	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ADH7—esophageal cancer	7.54e-05	0.00061	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GAPDH—esophageal cancer	7.29e-05	0.00059	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CRABP1—esophageal cancer	7.23e-05	0.000585	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HIST1H2BM—esophageal cancer	7.09e-05	0.000574	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PDE4D—esophageal cancer	7.03e-05	0.000569	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CA2—esophageal cancer	6.98e-05	0.000565	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GNG7—esophageal cancer	6.88e-05	0.000556	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	6.83e-05	0.000552	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	6.79e-05	0.00055	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CA1—esophageal cancer	6.69e-05	0.000541	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SLC10A2—esophageal cancer	6.69e-05	0.000541	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—GNG7—esophageal cancer	6.68e-05	0.000541	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ADH1B—esophageal cancer	6.61e-05	0.000535	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	6.6e-05	0.000534	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ADH7—esophageal cancer	6.49e-05	0.000525	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PLCE1—esophageal cancer	6.49e-05	0.000525	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	6.45e-05	0.000522	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ALDH2—esophageal cancer	6.44e-05	0.000521	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	6.42e-05	0.000519	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—ABL1—esophageal cancer	6.37e-05	0.000516	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—TYMP—esophageal cancer	6.32e-05	0.000511	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—XIAP—esophageal cancer	6.26e-05	0.000507	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP26A1—esophageal cancer	6.14e-05	0.000497	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GSTT1—esophageal cancer	6.13e-05	0.000496	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CA2—esophageal cancer	6.12e-05	0.000495	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CYP2A6—esophageal cancer	6.06e-05	0.00049	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ALOX15—esophageal cancer	5.99e-05	0.000485	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CTNNA1—esophageal cancer	5.92e-05	0.000479	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CXCL2—esophageal cancer	5.89e-05	0.000477	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	5.83e-05	0.000472	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ENO1—esophageal cancer	5.74e-05	0.000465	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PTGS1—esophageal cancer	5.74e-05	0.000465	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTO1—esophageal cancer	5.71e-05	0.000462	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—TPI1—esophageal cancer	5.71e-05	0.000462	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ADH1B—esophageal cancer	5.69e-05	0.000461	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PLCE1—esophageal cancer	5.69e-05	0.00046	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ADH7—esophageal cancer	5.69e-05	0.00046	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PSME1—esophageal cancer	5.66e-05	0.000458	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PSME2—esophageal cancer	5.66e-05	0.000458	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	5.64e-05	0.000456	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.57e-05	0.000451	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PSME2—esophageal cancer	5.5e-05	0.000445	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PSME1—esophageal cancer	5.5e-05	0.000445	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ALDOB—esophageal cancer	5.48e-05	0.000443	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ANXA1—esophageal cancer	5.47e-05	0.000443	CbGpPWpGaD
Alfentanil—ALB—Metabolism—TYMP—esophageal cancer	5.44e-05	0.00044	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	5.37e-05	0.000434	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.34e-05	0.000432	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—SST—esophageal cancer	5.33e-05	0.000431	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP26A1—esophageal cancer	5.29e-05	0.000428	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GAPDH—esophageal cancer	5.27e-05	0.000427	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CRABP1—esophageal cancer	5.22e-05	0.000423	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—GHRL—esophageal cancer	5.19e-05	0.00042	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NOTCH3—esophageal cancer	5.19e-05	0.00042	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ALOX15—esophageal cancer	5.16e-05	0.000417	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FBXW7—esophageal cancer	5.11e-05	0.000413	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ADH1B—esophageal cancer	4.99e-05	0.000404	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GNG7—esophageal cancer	4.97e-05	0.000402	CbGpPWpGaD
Alfentanil—ALB—Metabolism—TPI1—esophageal cancer	4.92e-05	0.000398	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTO1—esophageal cancer	4.92e-05	0.000398	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CYP1B1—esophageal cancer	4.88e-05	0.000395	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.88e-05	0.000395	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—BLVRB—esophageal cancer	4.85e-05	0.000392	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SLC52A3—esophageal cancer	4.85e-05	0.000392	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—TYMP—esophageal cancer	4.77e-05	0.000386	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ALDOB—esophageal cancer	4.72e-05	0.000382	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	4.68e-05	0.000378	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ALDH2—esophageal cancer	4.66e-05	0.000377	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NOTCH2—esophageal cancer	4.66e-05	0.000377	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP26A1—esophageal cancer	4.64e-05	0.000375	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—NOS2—esophageal cancer	4.59e-05	0.000372	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CYP19A1—esophageal cancer	4.59e-05	0.000371	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	4.58e-05	0.00037	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GAPDH—esophageal cancer	4.54e-05	0.000367	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALOX15—esophageal cancer	4.52e-05	0.000366	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CRABP1—esophageal cancer	4.5e-05	0.000364	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTT1—esophageal cancer	4.43e-05	0.000358	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP2A6—esophageal cancer	4.38e-05	0.000354	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTO1—esophageal cancer	4.31e-05	0.000349	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—TPI1—esophageal cancer	4.31e-05	0.000349	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GNG7—esophageal cancer	4.28e-05	0.000346	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—HMOX1—esophageal cancer	4.19e-05	0.000339	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ENO1—esophageal cancer	4.15e-05	0.000336	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PTGS1—esophageal cancer	4.15e-05	0.000336	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALDOB—esophageal cancer	4.13e-05	0.000334	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TGFBR2—esophageal cancer	4.13e-05	0.000334	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—CREBBP—esophageal cancer	4.13e-05	0.000334	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SLC10A2—esophageal cancer	4.12e-05	0.000333	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CA1—esophageal cancer	4.12e-05	0.000333	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PSME2—esophageal cancer	4.09e-05	0.000331	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PSME1—esophageal cancer	4.09e-05	0.000331	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	4.03e-05	0.000326	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ABCB1—esophageal cancer	4.02e-05	0.000325	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ALDH2—esophageal cancer	4.01e-05	0.000325	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GAPDH—esophageal cancer	3.98e-05	0.000322	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	3.97e-05	0.000321	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CRABP1—esophageal cancer	3.94e-05	0.000319	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—SMAD4—esophageal cancer	3.91e-05	0.000316	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	3.84e-05	0.000311	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTT1—esophageal cancer	3.81e-05	0.000309	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP2A6—esophageal cancer	3.77e-05	0.000305	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CA2—esophageal cancer	3.77e-05	0.000305	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.76e-05	0.000304	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GNG7—esophageal cancer	3.75e-05	0.000303	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—NOS3—esophageal cancer	3.69e-05	0.000299	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PTGS1—esophageal cancer	3.57e-05	0.000289	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ENO1—esophageal cancer	3.57e-05	0.000289	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.57e-05	0.000289	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP1B1—esophageal cancer	3.53e-05	0.000286	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PSME2—esophageal cancer	3.52e-05	0.000285	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PSME1—esophageal cancer	3.52e-05	0.000285	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALDH2—esophageal cancer	3.51e-05	0.000284	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PLCE1—esophageal cancer	3.5e-05	0.000284	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ADH7—esophageal cancer	3.5e-05	0.000284	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTT1—esophageal cancer	3.34e-05	0.00027	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP19A1—esophageal cancer	3.32e-05	0.000268	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP2A6—esophageal cancer	3.3e-05	0.000267	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HIF1A—esophageal cancer	3.2e-05	0.000259	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ENO1—esophageal cancer	3.13e-05	0.000253	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PTGS1—esophageal cancer	3.13e-05	0.000253	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.13e-05	0.000253	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PSME1—esophageal cancer	3.09e-05	0.00025	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PSME2—esophageal cancer	3.09e-05	0.00025	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.08e-05	0.000249	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ADH1B—esophageal cancer	3.07e-05	0.000249	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—KDR—esophageal cancer	3.06e-05	0.000248	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP1B1—esophageal cancer	3.04e-05	0.000246	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—HMOX1—esophageal cancer	3.03e-05	0.000245	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—TYMP—esophageal cancer	2.94e-05	0.000238	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ABCB1—esophageal cancer	2.91e-05	0.000235	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NOTCH1—esophageal cancer	2.88e-05	0.000233	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP19A1—esophageal cancer	2.86e-05	0.000231	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP26A1—esophageal cancer	2.86e-05	0.000231	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—EP300—esophageal cancer	2.81e-05	0.000227	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.78e-05	0.000225	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CREBBP—esophageal cancer	2.69e-05	0.000217	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP1B1—esophageal cancer	2.66e-05	0.000215	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.66e-05	0.000215	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—TPI1—esophageal cancer	2.66e-05	0.000215	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CREBBP—esophageal cancer	2.61e-05	0.000211	CbGpPWpGaD
Alfentanil—ALB—Metabolism—HMOX1—esophageal cancer	2.61e-05	0.000211	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—EGFR—esophageal cancer	2.57e-05	0.000208	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.56e-05	0.000207	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALDOB—esophageal cancer	2.55e-05	0.000206	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP19A1—esophageal cancer	2.5e-05	0.000203	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ABCB1—esophageal cancer	2.5e-05	0.000203	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	2.45e-05	0.000199	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GAPDH—esophageal cancer	2.45e-05	0.000198	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CRABP1—esophageal cancer	2.43e-05	0.000197	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—NOS3—esophageal cancer	2.41e-05	0.000195	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NOS3—esophageal cancer	2.34e-05	0.000189	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GNG7—esophageal cancer	2.31e-05	0.000187	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—HMOX1—esophageal cancer	2.28e-05	0.000185	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PIK3CA—esophageal cancer	2.23e-05	0.00018	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PTGS2—esophageal cancer	2.2e-05	0.000178	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ERBB2—esophageal cancer	2.19e-05	0.000177	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALDH2—esophageal cancer	2.17e-05	0.000175	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3CA—esophageal cancer	2.08e-05	0.000168	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTT1—esophageal cancer	2.06e-05	0.000167	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP2A6—esophageal cancer	2.04e-05	0.000165	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—TP53—esophageal cancer	2.01e-05	0.000163	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CREBBP—esophageal cancer	1.94e-05	0.000157	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CCND1—esophageal cancer	1.93e-05	0.000156	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ENO1—esophageal cancer	1.93e-05	0.000156	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.93e-05	0.000156	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PSME2—esophageal cancer	1.9e-05	0.000154	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PSME1—esophageal cancer	1.9e-05	0.000154	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.89e-05	0.000153	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CDKN1A—esophageal cancer	1.87e-05	0.000151	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—EP300—esophageal cancer	1.83e-05	0.000148	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—EP300—esophageal cancer	1.78e-05	0.000144	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—NOS3—esophageal cancer	1.74e-05	0.000141	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CREBBP—esophageal cancer	1.67e-05	0.000135	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.64e-05	0.000133	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PTGS2—esophageal cancer	1.59e-05	0.000129	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MYC—esophageal cancer	1.55e-05	0.000125	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.54e-05	0.000125	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—EGFR—esophageal cancer	1.52e-05	0.000123	CbGpPWpGaD
Alfentanil—ALB—Metabolism—NOS3—esophageal cancer	1.5e-05	0.000121	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CREBBP—esophageal cancer	1.47e-05	0.000119	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.41e-05	0.000114	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PTGS2—esophageal cancer	1.37e-05	0.000111	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CA—esophageal cancer	1.35e-05	0.00011	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.35e-05	0.000109	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—EP300—esophageal cancer	1.32e-05	0.000107	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CA—esophageal cancer	1.32e-05	0.000107	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NOS3—esophageal cancer	1.31e-05	0.000106	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TP53—esophageal cancer	1.27e-05	0.000103	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PTGS2—esophageal cancer	1.2e-05	9.71e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—EP300—esophageal cancer	1.14e-05	9.22e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—EP300—esophageal cancer	9.98e-06	8.08e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CA—esophageal cancer	9.79e-06	7.92e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CREBBP—esophageal cancer	9.03e-06	7.31e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CA—esophageal cancer	8.43e-06	6.82e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NOS3—esophageal cancer	8.09e-06	6.54e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PTGS2—esophageal cancer	7.39e-06	5.98e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CA—esophageal cancer	7.38e-06	5.98e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—EP300—esophageal cancer	6.15e-06	4.98e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CA—esophageal cancer	4.55e-06	3.68e-05	CbGpPWpGaD
